CHANTILLY, Va., Oct. 29, 2018 /PRNewswire/ -- Engility Holdings, Inc. (NYSE: EGL) won a prime contractor position on the DOD Joint Enterprise - Omnibus Program, Engineering, and Technical Support - Logistics & Medical contract. This multiple award, indefinite delivery, indefinite quantity contract has a ceiling value of $249 million. The company will assist the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense in serving as the total life cycle systems manager for chemical and biological defense programs with the DOD.
"We are very proud to have Engility's recognized medical and logistics experts contribute to this vital program that provides mission support to JPEO-CBRND," said Lynn Dugle, Engility CEO, chairman and president. "We are honored by the opportunity to contribute to the DOD mission in the critical CBRN arena."
Engility will bid on task orders to provide professional, logistics and medical solutions in support of the DOD around the world. Professional support can include program management and technical expertise. Logistics work would include support associated with development, production, fielding and maintenance and sustainment of a JPEO-CBRND program of record. Medical support may include product concept and design, and policy and protocol development of all JPEO-CBRND systems relating to biologics, vaccines and pharmaceuticals.
The contract has a five-year base period of performance and a one-year option, with a possible additional six month option.
About Engility
Engility (NYSE: EGL), a $2 billion technology leader, has thousands of employees around the world working to make a difference. Our history of delivering results for the defense, federal civilian, intelligence and space industries spans more than 60 years. We provide leading-edge solutions and services on Earth, in space and across cyber by leveraging expertise in systems engineering & integration, high performance computing, cybersecurity, readiness & training, enterprise modernization and mission operations support. To learn more about us, please visit www.engility.com and connect with us on Facebook, LinkedIn and Twitter.
Media: |
Investor Relations: |
Scott Fazekas |
Dave Spille |
Engility Holdings, Inc. (703) 984-5068 |
Engility Holdings, Inc. (703) 984-6120 |
SOURCE Engility Holdings, Inc.
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article